Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with fluzoparib and chemotherapy or fluzoparib in ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer [Phase 1]
Phase 1 trial evaluating a radiolabeled monoclonal antibody in patients with advanced ovarian epithelial cancer has completed, with results …
-
CLINICAL_TRIALS trial_result · 2021-12-20Clinical Trial Update: Study on Pembrolizumab in Recurrent, Platinum Resistant, CPS >1 Positive Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients [Phase 2]
Phase 2 study evaluating pembrolizumab in recurrent, platinum-resistant ovarian, fallopian tube, and primary peritoneal cancers with CPS > 1…
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors [Phase 1]
A Phase 1 dose-escalation study of PF-06801591 in multiple solid tumors including melanoma, head and neck cancer, ovarian cancer, sarcoma, n…
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer [Phase 3]
Phase 3 trial comparing TQB2450 with Anlotinib capsules versus Paclitaxel weekly for relapsed platinum-resistant ovarian cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer [Phase 2]
Phase 2 trial of TPIV200/huFR-1 vaccine plus durvalumab in platinum-resistant ovarian cancer completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-11-15Clinical Trial Update: A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1, Phase 2]
Clinical trial update for an autologous oxidized tumor cell lysate vaccine in recurrent ovarian/fallopian tube/primary peritoneal cancer; tr…
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients
Non-interventional European study evaluating trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer has completed with …
-
CLINICAL_TRIALS trial_result · 2021-10-11Clinical Trial Update: Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients [Phase 3]
Phase 3 multicenter trial evaluating maintenance monotherapy with olaparib in platinum-sensitive relapsed non-germline BRCA mutated ovarian …
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED) [Phase 3]
Phase 3 study evaluating EC145 in combination with Doxil for platinum-resistant ovarian cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer [NA]
Trial investigating behavioral economics strategies to improve quality of life in ovarian cancer has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 clinical trial update for a vaccine therapy in ovarian epithelial, primary peritoneal, or fallopian tube cancer with completed statu…
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer. [Phase 2]
Phase 2 trial evaluating decitabine plus carboplatin versus physician's choice chemotherapy for recurrent, platinum-resistant ovarian cancer…
-
CLINICAL_TRIALS trial_result · 2021-09-02Clinical Trial Update: Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 study examining whether physical activity tracked by Fitbit Charge 2 improves quality of life in participants with recurrent ovarian…
-
CLINICAL_TRIALS trial_result · 2021-09-01Clinical Trial Update: Efficacy and Safety of Niraparib Combined With Oral Etoposide in Platinum Resistant/Refractory Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial evaluating niraparib plus oral etoposide in platinum-resistant/refractory recurrent ovarian cancer; efficacy and safety data a…
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: Trial on NIraparib-TSR-042 (Dostarlimab) vs Physician's Choice CHEmotherapy in Recurrent, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment [Phase 3]
A Phase 3 trial comparing Niraparib-TSR-042 (Dostarlimab) to physician's choice chemotherapy in recurrent ovarian/fallopian tube/primary per…
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca, Selected According to HRD Status, in Patients With Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer, Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination [Phase 1, Phase 2]
A phase 1/2 trial comparing carboplatin-paclitaxel-bevacizumab with alternative regimens including rucaparib, selected by HRD status, in adv…
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer [Phase 1]
A Phase 1 clinical trial evaluating a monoclonal antibody therapy in patients with ovarian cancer scheduled for surgery was terminated; resu…
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating atezolizumab in combination with neoadjuvant chemotherapy for newly diagnosed advanced-stage ovarian cancer has c…
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: A Study to Evaluate Dual mTORC1/2 Inhibitor (ATG 008) or Selective Inhibitor of Nuclear Export Compound (ATG-010) in Combination With Chemotherapy in Patients With Relapsed or Metastatic Ovarian Cancer, Endometrial Cancer, and Cervical Cancer ( PORCH ) [Phase 2]
Phase 2 trial evaluating ATG 008 (dual mTORC1/2 inhibitor) or ATG-010 (selective exportin 1 inhibitor) in combination with chemotherapy for …
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Reprab Study: PLD + Trabectedin Rechallenge [Phase 2]
Phase 2 trial update for PLD + Trabectedin rechallenge in relapsed ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites [NA]
Clinical trial update for Canady Helios cold plasma scalpel at surgical margins and macroscopic tumor sites; status and results data are unc…
-
CLINICAL_TRIALS trial_result · 2021-08-05Clinical Trial Update: Analyzing the Composition of Tears to Identify Cancer [Phase 1, Phase 2]
Phase 1/2 trial exploring tear composition as a biomarker approach for cancer detection, involving breast and ovarian cancer cohorts.
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer [Phase 2]
A Phase 2 trial evaluating pembrolizumab in combination with pegylated liposomal doxorubicin for recurrent platinum-resistant ovarian, fallo…
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer [Phase 3]
A Phase 3 clinical trial evaluating optimal treatment with bevacizumab in patients with platinum-sensitive recurrent ovarian cancer has comp…